Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,186 INR | -1.23% | -4.00% | +9.38% |
May. 27 | Aurobindo Pharma Clocks Gains in Fiscal Q4 Consolidated Net Profit | MT |
May. 27 | Transcript : Aurobindo Pharma Limited, Q4 2024 Earnings Call, May 27, 2024 |
ETFs positioned on Aurobindo Pharma
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.32% | 6 M€ | +6.07% | - | |
0.22% | 19 M€ | +6.80% | ||
0.12% | 11 M€ | +2.67% | ||
0.09% | 1 M€ | +3.49% | - | |
0.09% | 3 M€ | -.--% | - | |
0.05% | 454 M€ | +4.02% | - | |
0.05% | 2,867 M€ | +5.89% | - | |
0.05% | 153 M€ | +3.74% | - | |
0.03% | 4 M€ | -4.41% | - | |
0.02% | 112 M€ | +4.61% | - | |
0.01% | 9 M€ | +27.69% | - | |
0.01% | 32 M€ | +6.87% | - | |
0.01% | 7 M€ | +5.36% | - | |
0.00% | 34 M€ | +3.86% | - | |
0.00% | 15 M€ | +15.88% | ||
0.00% | 45 M€ | -.--% | - | |
0.00% | 14 M€ | -5.07% | ||
0.00% | 34 M€ | +7.50% | - | |
0.00% | 391 M€ | +7.63% | - | |
0.00% | 39 M€ | +5.00% | - | |
0.00% | 306 M€ | +5.07% | - | |
0.00% | 17 M€ | +2.42% | - | |
0.00% | 105 M€ | +2.97% | - | |
0.00% | 54 M€ | +0.47% | - | |
0.00% | 8 M€ | +0.25% | - |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.38% | 8.32B | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
+9.78% | 210B | |
-5.52% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- AUROPHARMA Stock
- Funds and ETFs Aurobindo Pharma